Health Condition 1: E113- Type 2 diabetes mellitus with ophthalmic complications
Conditions
Interventions
Intervention1: Intravitreal Dexamethasone Implant: Single intravitreal injection of dexamethasone implant (0.7 mg) will be administered under aseptic precautions. Patients will be followed up at Day 1
Sponsors
Base Hospital, Delhi Cantt
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria : 1. Age greater than or equal to 18 yrs, able and willing to provide written informed consent 2.Type 2 DM 3. Center-involving Diabetic Macular Edema 4. Hba1c less than or equal to 8 percent
Exclusion criteria
Exclusion criteria: 1. Proliferative diabetic retinopathy 2. Ischemic maculopathy 3. H/o intravitreal drug therapy in last 6 months 4. H/o any intraocular surgery or laser in last 1 year 5. Media opacity precluding examination 6. Diagnosed cases of Glaucoma or ocular HTN on treatment 7. Any other ocular disease 8. Any cardiovascular event in last 6 months 9. Nephropathy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Central Macular Thickness(CMT) 2. Best Corrected Visual Acuity(BCVA)Timepoint: Day 1 , Week 4 , Week 12, week 16, Week 20, Week 24, Week 32 ,Week 40, Week 48 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Complications associated with Injections. 2. Number of Injections required in each groupTimepoint: Day 1 , Week 4 , Week 12, week 16, Week 20, Week 24, Week 32 ,Week 40, Week 48 | — |
Countries
India
Contacts
Public ContactDr K Shankar Gouda
Base Hospital, Delhi Cantt
Outcome results
None listed